5.1968
Immucell Corp Aktie (ICCC) Neueste Nachrichten
ImmuCell Corporation (NASDAQ:ICCC) Q1 2025 Earnings Call Transcript - Insider Monkey
Earnings call transcript: ImmuCell’s Q1 2025 revenue hits record, stock surges - Investing.com
ImmuCell Q2 2025 slides: sales momentum continues as Re-Tain awaits FDA approval - Investing.com
ImmuCell Corporation Q1 2025 Financial Results - TradingView
ImmuCell To Announce Unaudited Financial Results For the Quarter Ended March 31, 2025 - Barchart.com
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2025 - Stock Titan
Geode Capital Management LLC Boosts Stock Holdings in ImmuCell Co. (NASDAQ:ICCC) - Defense World
ImmuCell Co. (NASDAQ:ICCC) Short Interest Update - Defense World
ImmuCell (NASDAQ:ICCC) Stock Crosses Above 200-Day Moving Average – Should You Sell? - Defense World
The Zacks Analyst Blog Netflix, SAP SE, Shell, Preformed Line Products and ImmuCell - Yahoo Finance
ImmuCell (NASDAQ:ICCC) Stock Crosses Above 200 Day Moving Average – What’s Next? - Defense World
ImmuCell reports record sales in first quarter of 2025 - Investing.com
Record Quarter: ImmuCell Crushes Sales Estimates with $8.1M Revenue Milestone - Stock Titan
ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 of 2025 - The Globe and Mail
ImmuCell appoints new CFO to bolster growth strategy - Investing.com
ImmuCell Strengthens Leadership: 24-Year IDEXX Finance Expert Takes CFO Role - Stock Titan
ImmuCell Hires Chief Financial Officer - The Globe and Mail
ImmuCell Full Year 2024 Earnings: US$0.26 loss per share (vs US$0.74 loss in FY 2023) - Yahoo Finance
Revolutionary Antibiotic-Free Mastitis Treatment Enters Market Testing Phase - Stock Titan
IMMUCELL CORP /DE/ SEC 10-K Report - TradingView
ImmuCell (NASDAQ:ICCC) Stock Passes Above 200 Day Moving Average – Time to Sell? - Defense World
ImmuCell (NASDAQ:ICCC) Stock Price Passes Above 200-Day Moving Average – Should You Sell? - Defense World
ImmuCell Corp. to Host Earnings Call - ACCESS Newswire
ImmuCell Posts Y/Y Q4 Earnings Growth, Awaits FDA Approval For Re-Tain - Barchart.com
ImmuCell Corp (ICCC) Q4 2024 Earnings Call Highlights: Strong Sales Growth and Operational ... By GuruFocus - Investing.com Canada
ImmuCell Corporation (NASDAQ:ICCC) Q4 2024 Earnings Call Transcript - Insider Monkey
Earnings call transcript: ImmuCell sees strong Q4 2024 sales growth - Investing.com
ImmuCell Corporation Reports Strong Financial Performance for Q4 and Full Year 2024 - TradingView
Animal Health Pioneer ImmuCell Sets Stage for Critical Year-End Financial Reveal - StockTitan
The Zacks Analyst Blog Highlights Apple, Eli Lilly, Shopify and ImmuCell - Yahoo Finance
Top Stock Reports for Apple, Eli Lilly & Shopify - Yahoo Finance
ImmuCell (NASDAQ:ICCC) Stock Price Passes Above 200-Day Moving Average – Here’s What Happened - Defense World
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
ImmuCell (NASDAQ:ICCC) Stock Passes Above 200 Day Moving Average – What’s Next? - Defense World
ImmuCell Settles Insurance Claim for Production Contamination Events - Defense World
ImmuCell settles insurance claim for production losses - Investing.com
ImmuCell Secures $426,587 Additional Insurance Settlement for Production Contamination Issues - StockTitan
ImmuCell Announces Strong Preliminary Sales Results for Q4 and Full Year 2024 - Defense World
ImmuCell Sales Surge 52% to Record $26.5M as Production Hits Full Capacity - StockTitan
ImmuCell (NASDAQ:ICCC) Shares Pass Above 200 Day Moving Average – Here’s What Happened - Defense World
ImmuCell announces executive transition with part-time agreement By Investing.com - Investing.com South Africa
ImmuCell announces executive transition with part-time agreement - Investing.com
Zacks Initiates Coverage of ImmuCell With Neutral Recommendation - Yahoo Finance
The Zacks Analyst Blog Highlights Amazon.com, Stryker, Lam Research and ImmuCell - Yahoo Finance
Top Research Reports for Amazon, Stryker & Lam Research - Yahoo Finance
ImmuCell amends agreement with Norbrook Labs - Investing.com
ImmuCell Q3 Earnings Decline Y/Y, Sales Grow Amid Margin Challenges - MSN
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):